Steward Financial Group’s AstraZeneca AZN Stock Holding History

Steward Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$43K	Hold	320	–	–	0.01%	162
2023 Q2	$45K	Buy	320 +146	+84%	+$21.5K	0.01%	152
2023 Q1	$24K	Hold	174	–	–	0.01%	123
2022 Q4	$23K	Buy	+174	New	+$21.8K	0.01%	109
2022 Q3	–	Sell	-174	Closed	-$22K	–	174
2022 Q2	$22K	Buy	+174	New	+$22.8K	0.02%	164

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Steward Financial Group's AZN Position: Q3 2023 in Review

Steward Financial Group held its AstraZeneca (AZN) position steady in Q3 2023 at 320 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #162.

Steward Financial Group first reported a position in AZN in Q2 2022 and has held it in 5 quarters since. The position peaked at $45K in Q2 2023. 1,074 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

Steward Financial Group held 320 shares of AstraZeneca worth $43K as of Q3 2023.
Steward Financial Group left its AstraZeneca share count unchanged in Q3 2023.
AstraZeneca made up 0.01% of Steward Financial Group's portfolio in Q3 2023, its #162 holding.
Steward Financial Group first reported a position in AstraZeneca in Q2 2022 and has held it in 5 quarters since.
Steward Financial Group's AstraZeneca position peaked at $45K in Q2 2023.
1,074 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.